Antithrombin-lowering in hemophilia: a closer look at fitusiran
Por um escritor misterioso
Descrição
Gene therapy in haemophilia: literature review and regional perspectives for Turkey - Kaan Kavaklı, Bülent Antmen, Vahap Okan, Fahri Şahin, Selin Aytaç, Can Balkan, Ergül Berber, Zühre Kaya, Alphan Küpesiz, Bülent Zülfikar
Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect
A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
HEMLIBRA: Potential Treatment for Hemophilia A Patients
Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
Fitusiran reduces bleeding events in patients with severe haemophilia - BJH
Summer 2022 haemophilia trial update - European Pharmaceutical Review
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort - Pasi - 2021 - Journal of Thrombosis and Haemostasis - Wiley Online Library
A Molecular Revolution in the Treatment of Hemophilia: Molecular Therapy
Fitusiran update following EAHAD 2021 Congress – WFH - World Federation of Hemophilia
Antithrombin-lowering in hemophilia: a closer look at fitusiran - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
:max_bytes(150000):strip_icc()/5351973-c6293b44c0fe481b9ae2920e31b5bc74.jpg)
